scholarly journals Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study

2014 ◽  
Vol 187 (2) ◽  
pp. E74-E81 ◽  
Author(s):  
Leah M. Smith ◽  
Jay S. Kaufman ◽  
Erin C. Strumpf ◽  
Linda E. Lévesque
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Olivia Remes ◽  
Leah M Smith ◽  
Beatriz E Alvarado-Llano ◽  
Lindsey Colley ◽  
Linda E Lévesque

2020 ◽  
Vol 110 (3) ◽  
pp. 385-390
Author(s):  
Demetria Hubbard ◽  
Sadeep Shrestha ◽  
Emily B. Levitan ◽  
Huifeng Yun

Objectives. To determine rates of human papillomavirus (HPV) vaccine adherence to the 2011 and 2016 Advisory Committee for Immunization Practices (ACIP) recommendations in the United States. Methods. We conducted a retrospective cohort study by using the 2011 to 2017 Marketscan data for beneficiaries aged 9 to 26 years who had at least 1 claim for HPV vaccination between January 1, 2011, and January 1, 2017. According to the 2011 ACIP recommendation, adherence is defined as 30 to 90 days between the first and second vaccination and 168 to 212 days between the first and third vaccination. According to the 2016 recommendation, preadolescents are classified as adherent if they had 2 claims of vaccination within 168 to 212 days. We calculated proportions of completion and adherence by recommendation. Results. Among patients classified under the 2011 ACIP recommendation (n = 2 164 096), 8.3% completed all 3 doses of the vaccine series. Of those who completed, 69.6% were considered adherent to the recommended schedule. Completion and adherence increased to 9.6% and 70.8%, respectively, among patients who were classified under the 2016 ACIP recommendation. Conclusions. Simpler recommendations lead to better adherence to the HPV vaccination schedule.


2018 ◽  
Vol 190 (21) ◽  
pp. E648-E655 ◽  
Author(s):  
Erin Y. Liu ◽  
Leah M. Smith ◽  
Anne K. Ellis ◽  
Heather Whitaker ◽  
Barbara Law ◽  
...  

Author(s):  
Seema Kumari ◽  
Aradhana Singh ◽  
Renu Sangal ◽  
Neela R. Sharma

Background: Human papillomavirus (HPV) is the most common sexually transmitted infection and is a causal factor for cervical cancer in virtually 100% cases. Despite the availability of highly effective vaccine against HPV, the burden of this dreaded disease remains high in our country. The aim of this study was to study the knowledge, attitude and practices on cervical cancer and HPV vaccine among adolescent girls of Eastern UP and to study the factors influencing knowledge, attitude and practices towards HPV vaccination among adolescent girls of this region.Methods: This was a questionnaire based cross-sectional study. Purposive sampling was used. Sample consisted of adolescent girls attending Gynecological OPD of a tertiary care center of Eastern UP, for a period of one year and the sample size was 384.Results: The results showed that, only 8.07% participants had heard of HPV infection and 2.08% participants had HPV vaccine knowledge. 35.95% participants agreed that their parents would pay for vaccine and 79.17% participants agreed for vaccination, if it would be free of cost. In total, most of the participants in the sample were found to have a positive attitude towards the vaccine.Conclusions: Although the knowledge and awareness of cervical cancer and its prevention through HPV vaccination, was poor among adolescent girls of Eastern UP region, it was encouraging to find, that most of them had a positive attitude towards HPV vaccination. It was also concluded, that the acceptability would increase, if the Government includes HPV vaccination in the National Immunization Program. If the cost constraint is dealt with, this completely preventable disease could be controlled in our country. 


Vaccines ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 496
Author(s):  
Caroline Deignan ◽  
Alison Swartz ◽  
Sara Cooper ◽  
Christopher J. Colvin

Cervical cancer rates in Sub-Saharan Africa (SSA) are amongst the highest worldwide. All three of the Human Papillomavirus (HPV) vaccines (9-valent, quadrivalent and bivalent HPV vaccine) provide primary protection against the most common cancer-causing strains of HPV (types 16 and 18) that are known to cause 70% of cervical cancers. Over the last five years, there has been an increase in Sub-Saharan African countries that have introduced the HPV vaccine. The majority of research has been conducted on supply-side barriers and facilitators to HPV vaccination uptake in SSA, yet little research has been conducted on demand-side or end-user perspectives of, and decisions around, HPV vaccination. In order to complement existing research, and inform current and future HPV vaccination implementation approaches, this qualitative systematic review explored Stakeholders’ understandings of HPV vaccination in SSA. This review searched the following databases: Embase (via Scopus), Scopus, MEDLINE (via PubMed), PubMed, EBSCOhost, Academic Search Premier, Africa-Wide Information, CINAHL, PsycARTICLES, PsycINFO, SocINDEX, Web of Science, and the Cochrane Controlled Register of Trials (CENTRAL) and found a total of 259 articles. Thirty-one studies were found eligible for inclusion and were analyzed thematically using Braun and Clarke’s methods for conducting a thematic analysis. The quality of included studies was assessed using the Critical Appraisal Skills Programme (CASP) checklist. Three major themes emerged from this analysis; knowledge of HPV vaccination and cervical cancer is intertwined with misinformation; fear has shaped contradictory perceptions about HPV vaccination and gender dynamics are relevant in how stakeholders understand HPV vaccination in SSA.


2017 ◽  
Vol 7 (6) ◽  
pp. 35 ◽  
Author(s):  
Kimberlee Dayal ◽  
Sarah Robinson ◽  
Jessica Schoening ◽  
Mary Catherine Smith ◽  
Son Chae Kim

Aim: The aim of this study was to examine predictors of human papillomavirus (HPV) vaccine uptake or intent among parents of pre-adolescents and adolescents.Methods: A cross-sectional descriptive study was conducted among parents of girls aged 9 to 18 years, visiting two primary care clinics in central Texas from September to November 2015. Pearson’s product-moment correlation procedures and path analyses based on Health Belief Model were performed.Results: Path analysis showed that provider recommendation for HPV vaccination (β = 0.37; p < .001) and perceived HPV vaccine harm (β = -0.48; p < .001) had statistically significant direct effects on HPV vaccine uptake or intent. The perceived HPV vaccine effectiveness was directly influenced by HPV knowledge (β = 0.39; p < .001), empowerment in parent-provider relationships (β = 0.30; p = .006) and parental college education (β = 0.23; p = .039).}Conclusions: Together with parental empowerment fostering an equal partnership with providers, targeted education to improve parental HPV knowledge may convince them of the HPV vaccine effectiveness. This, in turn, may help them put the perceived HPV vaccine harm in proper perspective and allow them to make informed decisions regarding the timely HPV vaccination of their children. Because provider recommendation is one of the most important contributing factors for HPV vaccine uptake or intent, parental education and recommendations from nurses will help reduce the knowledge gaps and empower parents to make the timely decisions to vaccinate their children.


Sign in / Sign up

Export Citation Format

Share Document